When the diagnosis is written in the DNA: a case of erythropoietic protoporphyria in a patient with a chromosome 18 deletion
We present a case of erythropoietic protoporphyria (EPP) in a 21-year-old man who sought medical attention in April 2022 due to diffuse edema and erythema of the hands, which he had been experiencing since childhood and occurring shortly after sun exposure. The patient's medical history reveal...
Main Authors: | Sara Rovaris, Giuseppe La Rosa, Sara Mezzana, Francesco Tonon, Luigi Mori, Eugenio Monti, Giuseppe Mazzeo, Piergiacomo Calzavara-Pinton, Mariachiara Arisi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2023-09-01
|
Series: | Dermatology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/dr/article/view/9784 |
Similar Items
-
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
by: Anna-Elisabeth Minder, et al.
Published: (2023-04-01) -
Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study
by: Jasmin Barman-Aksözen, et al.
Published: (2020-08-01) -
Erythropoietic Protoporphyria in a Japanese Population
by: Megumi Mizawa, et al.
Published: (2019-04-01) -
The 6-year follow-up of a Japanese patient with silent erythropoietic protoporphyria
by: Megumi Mizawa, MD, PhD, et al.
Published: (2017-05-01) -
Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria
by: Katelyn E. Madigan, et al.
Published: (2023-12-01)